The Low-FODMAP Diet Step by Step: Elimination, Reintroduction and Beyond

The Low-FODMAP Diet Step by Step: Elimination, Reintroduction and Beyond

Many people with inflammatory bowel disease (IBD) reach a point where their bloods look calm, their scope results are reassuring, yet they still feel bloated, gassy or unpredictable after eating. This gap between inflammation and symptoms is common, and it is often where the low-FODMAP diet becomes relevant. Understanding how this approach works, and how to use it properly, can help patients manage ongoing gut symptoms without over-restricting their diet unnecessarily.

What is the low-FODMAP diet?

FODMAP stands for fermentable oligosaccharides, disaccharides, monosaccharides and polyols, a group of short-chain carbohydrates found in foods such as wheat, onions, garlic, certain fruits, dairy and some sweeteners. These carbohydrates are poorly absorbed in the small intestine, so they travel further down the gut where they draw in water and are fermented by gut bacteria. The low-FODMAP diet temporarily reduces these foods to see whether digestive symptoms improve, then reintroduces them in a structured way to identify which specific types and amounts a person can tolerate.

Why it matters for gut inflammation

The low-FODMAP diet does not treat inflammation itself. It is a symptom-management tool, most useful when someone has IBD that is in remission or mildly active but still experiences bloating, wind, urgency or abdominal discomfort, patterns that overlap with irritable bowel syndrome (IBS)-type symptoms. Inflammation affects the gut lining and immune signalling, while FODMAP-related symptoms are largely driven by gas, stretching and gut sensitivity. Because both can produce similar sensations, distinguishing between the two matters for choosing the right management approach.

Key mechanisms

Fermentation and gas production

When FODMAPs reach the large intestine undigested, gut bacteria ferment them quickly, producing gas as a by-product. In a gut that is already sensitive, whether from previous inflammation, surgery or altered motility, this extra gas can cause noticeable bloating and cramping even without active disease.

Osmotic water movement

Some FODMAPs, particularly polyols and certain sugars, pull water into the bowel through osmosis. This can speed up transit and contribute to looser stools, which can be mistaken for a flare when it is actually a food-related effect rather than immune activity.

Visceral hypersensitivity

Long-standing inflammation can change how nerves in the gut wall perceive normal stretching and gas, a phenomenon known as visceral hypersensitivity. This means that even after inflammation settles, the gut may continue to signal discomfort more readily than before, which explains why some people with IBD in remission still experience IBS-like symptoms.

Microbiome shifts

Restricting FODMAPs for a prolonged period can reduce populations of beneficial gut bacteria, since these carbohydrates also act as fuel for organisms that support gut health. This is one reason the elimination phase is intended to be short and followed by reintroduction, rather than continued indefinitely.

It is worth reinforcing that symptoms do not always equal inflammation, and the low-FODMAP diet should not be used as a substitute for medical monitoring. Ongoing symptoms in IBD should always be discussed with a gastroenterologist or dietitian to rule out active disease, strictures or other complications before assuming they are purely diet-related.

The three phases of the low-FODMAP diet

Elimination

This phase typically lasts two to six weeks and involves significantly reducing high-FODMAP foods across all categories. The aim is to calm symptoms enough to establish a clearer baseline, not to eliminate these foods permanently.

Reintroduction

Once symptoms have settled, individual FODMAP groups are reintroduced one at a time, in gradually increasing amounts, while monitoring symptoms closely. This structured testing identifies which specific FODMAP types, and what quantities, tend to trigger discomfort for that person.

Personalisation

The final phase involves building a long-term, individualised diet that avoids only the specific triggers identified, while reintroducing everything else. This stage is essential for nutritional adequacy and for avoiding unnecessary long-term restriction, which can affect fibre intake, micronutrient levels and quality of life.

Practical takeaways

  • Work with a dietitian experienced in IBD before starting, since unsupervised elimination diets can lead to nutrient shortfalls.
  • Keep the elimination phase time-limited rather than open-ended.
  • Reintroduce foods systematically, one FODMAP group at a time, rather than all at once.
  • Track symptoms alongside disease activity markers where possible, not in isolation.
  • Avoid assuming every symptom means a flare, since gut sensitivity can persist after inflammation has resolved.
  • Aim for the least restrictive diet that still controls symptoms, rather than the most restrictive one.

Conclusion

The low-FODMAP diet can be a useful, structured way to manage persistent digestive symptoms in people with IBD, particularly when inflammation has settled but discomfort remains. It works by reducing fermentable carbohydrates that can cause gas, water shifts and stretching in a sensitive gut, but it is not a treatment for underlying inflammation and should not be used as one. Because long-term restriction carries its own risks, the diet is designed to move through elimination and reintroduction towards a personalised, less restrictive pattern of eating. Anyone considering this approach should do so alongside their gastroenterology or dietetic team, so that symptom changes can be interpreted correctly alongside overall disease monitoring.

References

  1. Gibson PR, Shepherd SJ. Evidence-based dietary management of functional gastrointestinal symptoms: the FODMAP approach. J Gastroenterol Hepatol. 2010;25(2):252-258. doi:10.1111/j.1440-1746.2009.06149.x
  2. Halmos EP, Power VA, Shepherd SJ, et al. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology. 2014;146(1):67-75. doi:10.1053/j.gastro.2013.09.046
  3. Prince AC, Myers CE, Joyce T, et al. Fermentable carbohydrate restriction (low FODMAP diet) in clinical practice improves functional gastrointestinal symptoms in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2016;22(5):1129-1136. doi:10.1097/MIB.0000000000000708
  4. Cox SR, Prince AC, Myers CE, et al. Fermentable carbohydrates [FODMAPs] exacerbate functional gastrointestinal symptoms in patients with inflammatory bowel disease: a randomised controlled trial. J Crohns Colitis. 2017;11(12):1420-1429. doi:10.1093/ecco-jcc/jjx073
  5. Staudacher HM, Whelan K. The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS. Gut. 2017;66(8):1517-1527. doi:10.1136/gutjnl-2017-313750
  6. Halmos EP, Christophersen CT, Bird AR, et al. Diets that differ in their FODMAP content alter the colonic luminal microenvironment. Gut. 2015;64(1):93-100. doi:10.1136/gutjnl-2014-307264

This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.

About the Author

Team Vance

Team Vance is the editorial team at Vance Medical, the medical foods company behind this hub. Vance Medical has spent more than thirty years in gastrointestinal medicine, developing nutritional products under the same regulatory frameworks that govern prescription medicines. The Hub exists to make that ground accessible, to people living with Crohn's disease, ulcerative colitis, IBS and related conditions, and to the clinicians treating them. Articles are written and edited in-house, and clinical claims are referenced to published research, with each study linked to its DOI so you can read the source rather than take our word for it. We publish primarily for a UK audience. Nothing here replaces advice from your own GP, gastroenterologist or dietitian.

For general information only. This article is for general information and is not a substitute for professional medical advice, diagnosis or treatment. It reflects the best available evidence at the time of writing and may not capture the most recent developments. Always talk to your GP, pharmacist or healthcare team before acting on anything you read here, and never disregard professional advice or delay seeking it because of something on this site. Where we mention products from Vance Medical Foods Ltd we identify this clearly.
Last updated 7 September 2026
×
×